More News

19 May 2007 KV Pharmaceutical Company (KVA) Announces Approval for Two Strengths of Generic Versions of Toprol-XL(R)
18 May 2007 Roche and Siena Biotech S.p.A. Enter Research Collaboration Agreement in Neurodegenerative Diseases
17 May 2007 Next Generation Nasal Spray Against Influenza: Clinical Phase I Study Started With FLUVACCdelNS1
17 May 2007 Organon and Medarex announce biotherapeutics development agreement
17 May 2007 Glenmark receives US FDA approval to market generic
17 May 2007 CollaGenex Pharmaceuticals and QuatRx Pharmaceuticals Announce Agreement for the Development and Commercialization of Becocalcidiol
17 May 2007 Ranbaxy Receives Tentative FDA Approval for Fexofenadine Hydrochloride Tablets
16 May 2007 Proteros Biostructures and Boehringer Ingelheim Pharmaceuticals Enter into Protein Crystallography Agreement
16 May 2007 Lupin Pharmaceuticals, Inc. Receives US FDA Approval for Simvastatin Tablets
15 May 2007 Skyepharma PLC and Sciele Pharma Announce Successful Completion of New Sular(R) Formulation Clinical Trial Programme
15 May 2007 BDSI Announces Positive Key Secondary Efficacy Endpoint Results for Bema Fentanyl
15 May 2007 GSK Returns Development Rights for MED2002
13 May 2007 Mylan Laboratories to Acquire Generics Business of Merck KGaA
12 May 2007 DermTech and UCSF Collaborate to Explore Potential of Company's EGIR Technology to Develop Novel Compounds for Anti-aging and Atopic Dermatitis
11 May 2007 FDA Approves Schwarz Pharma's Neupro (Rotigotine Transdermal System) for the Treatment of Early-Stage Parkinson's Disease in USA
11 May 2007 Teva Announces Approval and Shipment of Generic Omnicef(R) Capsules and POS
11 May 2007 Viropro Inc. and Intas Biopharmaceuticals Announce the Signature of a Binding MOU for the Development and Production of a Therapeutic Protein
11 May 2007 Gene Logic and Abbott Enter Collaboration to Discover New Development Paths for Multiple Clinical Drug Candidates
10 May 2007 Bristol-Myers Squibb Enters Cardiovascular Disease Collaboration With Isis Pharmaceuticals
09 May 2007 Focetria(R), the Novartis pandemic influenza vaccine, receives European Union approval
09 May 2007 Oramed Pharmaceuticals Begins Phase 1 Human Clinical Trials
09 May 2007 4SC AG Provides Proof of Concept for Drug Candidate SC75741 in the Treatment of Influenza A-infected Mice
09 May 2007 Inspire Announces Positive Results of Phase 2 Trial of Epinastine Nasal Spray for Seasonal Allergic Rhinitis
09 May 2007 Lupin Pharmaceuticals, Inc. Announces Final FDA Approval of Cefdinir for Oral Suspension, 250 mg/5 mL, Launches Entire Product Family
09 May 2007 Entelos and Jubilant Announce Alliance to Develop Therapeutics and Offer Joint Services

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2021 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up